| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10917987 | Radiotherapy and Oncology | 2015 | 6 Pages | 
Abstract
												DIL boosting was found to be feasible with all investigated techniques. Although OAR doses were higher than for standard treatment approach, the risk levels were reasonably low. HDR-BT was superior to VMAT and IMPT, both in terms of OAR sparing and DIL boosting.
											Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Piotr Andrzejewski, Peter Kuess, Barbara Knäusl, Katja Pinker, Petra Georg, Johannes Knoth, Daniel Berger, Christian Kirisits, Gregor Goldner, Thomas Helbich, Richard Pötter, Dietmar Georg, 
											